Literature DB >> 19258354

Memory performance is related to amyloid and tau pathology in the hippocampus.

C Reitz1, L Honig, J P Vonsattel, M-X Tang, R Mayeux.   

Abstract

OBJECTIVE: To determine the relation of amyloid and tau pathology in the hippocampal formation to decline in memory and other cognitive functions in Alzheimer's disease (AD).
METHODS: Regression models were used to relate semiquantitative measurements of amyloid plaques, neurofibrillary tangles (NFTs) and neuropil threads (NTs) at autopsy with antemortem performance in memory, abstract/visuospatial and language domains in two independent samples (n = 41, n = 66) that had repeated neuropsychological measurements before death.
RESULTS: In both groups, the number of NFTs in the entorhinal cortex, subiculum and CA1 region was inversely associated with memory performance at the last visit before death. However, the number of amyloid plaques and NTs in the entorhinal cortex was also inversely related to poor memory function. Moreover, as the number of plaques or NTs increased in any region of the hippocampal formation, there was a more rapid decline in memory performance over time; a similar decline was associated with increasing numbers of NFTs in the CA1 or subiculum. In contrast, there was no association between amyloid plaques, NFTs or NTs in the frontal or parietal lobe and performance in memory, nor was there an association between plaques, NFTs or NTs in the hippocampal formation and cognitive functions unrelated to memory. DISCUSSION: This study implicates both amyloid deposition and tau pathology in the hippocampus as an early and late cause of decline in memory function over time in AD. Memory performance appears to be specifically related to the amount of amyloid plaques, NFTs and NTs in the entorhinal cortex and hippocampus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258354      PMCID: PMC2785022          DOI: 10.1136/jnnp.2008.154146

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment.

Authors:  J H Kordower; Y Chu; G T Stebbins; S T DeKosky; E J Cochran; D Bennett; E J Mufson
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

Review 2.  Properties of entorhinal cortex projection cells to the hippocampal formation.

Authors:  U Heinemann; D Schmitz; C Eder; T Gloveli
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 3.  An emerging molecular and cellular framework for memory processing by the hippocampus.

Authors:  Gayle M Wittenberg; Joe Z Tsien
Journal:  Trends Neurosci       Date:  2002-10       Impact factor: 13.837

4.  Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Authors:  T Ishihara; M Hong; B Zhang; Y Nakagawa; M K Lee; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

5.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

Authors:  J Näslund; V Haroutunian; R Mohs; K L Davis; P Davies; P Greengard; J D Buxbaum
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

6.  The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.

Authors:  F García-Sierra; J J Hauw; C Duyckaerts; C M Wischik; J Luna-Muñoz; R Mena
Journal:  Acta Neuropathol       Date:  2000-07       Impact factor: 17.088

7.  Modelling cognitive dysfunctions with bilateral injections of ibotenic acid into the rat entorhinal cortex.

Authors:  M Eijkenboom; A Blokland; F J van der Staay
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.

Authors:  Thomas W Mitchell; Elliott J Mufson; Julie A Schneider; Elizabeth J Cochran; Jonathan Nissanov; Li-Ying Han; Julia L Bienias; Virginia M -Y Lee; John Q Trojanowski; David A Bennett; Steven E Arnold
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

9.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.

Authors:  Yoshitaka Tatebayashi; Tomohiro Miyasaka; De-Hua Chui; Takumi Akagi; Ken-ichi Mishima; Katsunori Iwasaki; Michihiro Fujiwara; Kentaro Tanemura; Miyuki Murayama; Koichi Ishiguro; Emmanuel Planel; Shinji Sato; Tsutomu Hashikawa; Akihiko Takashima
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

View more
  18 in total

1.  A method for inferring regional origins of neurodegeneration.

Authors:  Justin Torok; Pedro D Maia; Fon Powell; Sneha Pandya; Ashish Raj
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

Review 2.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

Review 3.  The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration.

Authors:  Laura L Kubik; Martin A Philbert
Journal:  Toxicol Sci       Date:  2015-03       Impact factor: 4.849

4.  The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Authors:  Reisa A Sperling; Elizabeth C Mormino; Aaron P Schultz; Rebecca A Betensky; Kathryn V Papp; Rebecca E Amariglio; Bernard J Hanseeuw; Rachel Buckley; Jasmeer Chhatwal; Trey Hedden; Gad A Marshall; Yakeel T Quiroz; Nancy J Donovan; Jonathan Jackson; Jennifer R Gatchel; Jennifer S Rabin; Heidi Jacobs; Hyun-Sik Yang; Michael Properzi; Dylan R Kirn; Dorene M Rentz; Keith A Johnson
Journal:  Ann Neurol       Date:  2019-01-21       Impact factor: 10.422

5.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

6.  Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography.

Authors:  Paul B Rosenberg; D F Wong; S L Edell; J S Ross; A D Joshi; J R Brašić; Y Zhou; V Raymont; A Kumar; H T Ravert; R F Dannals; M J Pontecorvo; D M Skovronsky; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-03       Impact factor: 4.105

7.  Biomarkers of Alzheimer's disease: from central nervous system to periphery?

Authors:  Enrico Mossello; Elena Ballini; Anna Maria Mello; Francesca Tarantini; David Simoni; Samuele Baldasseroni; Niccolò Marchionni
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

8.  Abnormal brain cholesterol homeostasis in Alzheimer's disease-a targeted metabolomic and transcriptomic study.

Authors:  Vijay R Varma; H Büşra Lüleci; Anup M Oommen; Sudhir Varma; Chad T Blackshear; Michael E Griswold; Yang An; Jackson A Roberts; Richard O'Brien; Olga Pletnikova; Juan C Troncoso; David A Bennett; Tunahan Çakır; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  NPJ Aging Mech Dis       Date:  2021-06-01

9.  Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease.

Authors:  Nilüfer Ertekin-Taner; Phillip L De Jager; Lei Yu; David A Bennett
Journal:  Curr Genet Med Rep       Date:  2013-01-22

10.  Memantine combined with environmental enrichment improves spatial memory and alleviates Alzheimer's disease-like pathology in senescence-accelerated prone-8 (SAMP8) mice.

Authors:  Jingde Dong; Mi Zhou; Xiaoqiang Wu; Mingyang Du; Xiaoshan Wang
Journal:  J Biomed Res       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.